Bystolic Tablet
Pricing Report NDC 0456-1402-63

Latest NADAC: $5.57050 per EA · Effective Jan 03, 2023 · Est. package price $557.05 (100 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Bystolic (NDC 0456-1402-63) is $5.57050 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 03, 2023.

As a a human prescription drug provided by Allergan, Inc., this medication is distributed in a 100 TABLET in 1 BOX, UNIT-DOSE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.57050
Per EA

Effective Date
Jan 03, 2023
Billable Units
100 EA
Estimated Package Price
$557.05
Data Status
As of Mar 29, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET in 1 BOX, UNIT-DOSE
Generic Benchmark
The generic equivalent rate is $0.21067 (Effective: Mar 22, 2023)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2013, the NADAC wholesale price for (NDC ) has moved within a range of $2.37859 to $6.49728 per EA. Over this 13 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.3786 - $6.4973
Market Volatility
173.16% Variance
Latest Trend
0.08%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $6.45441 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $6.45982 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $6.46093 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $6.49728 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 02, 2026 $6.43806 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 02, 2026 $6.43806 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 02, 2026 $6.43806 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 02, 2026 $6.43806 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 02, 2026 $6.43806 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $6.13142 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $6.13456 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $6.13219 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026